China Universal Asset Management Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 72,509 shares of LXRX stock, worth $50,031. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,509
Previous 76,650
5.4%
Holding current value
$50,031
Previous $56,000
41.07%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$94 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.82 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$6.59 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$5.67 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.55 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $130M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...